A novel binuclear zinc(II) complex [Zn2(azpy)3(2Cl-azpy)2(H2O)6](ClO4)4(azpy)4(H2O)10 (1) (azpy = 4,4′-azopyridine, 2Cl-azpy = (2,6-dichloro)-4,4′-azopyridine) has been synthesized and characterized by single crystal X-ray diffraction, IR and excitation and emission spectra. The Complex 1 crystallizes in the triclinic space group , with a = 10.730(3), b = 15.455(4), c = 18.893(5) Å, α = 73.358(5), β = 87.999(6), γ = 71.865(6)°, V = 2847.7(14) Å3, Z = 1. The azpy ligand links two zinc(II) ions forming a binuclear entity. Each zinc(II) ion lies in a distorted octahedron completed by three oxygen atoms from water molecules and three nitrogen atoms from 4-pyridyl donor groups. Luminescence studies of 1 in aqueous solution show strong blue photoluminescence as the result of fluorescence from an intraligand excited state.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2003) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: